Picard Medical Inc (PMI) Stock Analysis
Verdict: AVOID
Severe cash burn with under 6 months of runway and heavy net losses make PMI a high-dilution risk microcap despite SynCardia TAH tech.
Investment score: 18/100
Analysis as of
Is Picard Medical Inc stock worth reviewing? AI model thesis
The model views PMI as an extreme-risk microcap micro-float stock with severe cash burn ($15.67M FCF deficit in 2025) and under 6 months of liquidity. The model sees high probability of dilutive financing before Q3 2026, making the equity unsuited for fundamental investors.
7-factor investment score
- Valuation: 20/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 15/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 25/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Picard Medical Inc opportunities and risks
What speaks for PMI
- Proprietary SynCardia TAH Technology
What speaks against PMI
- Imminent Cash Runway Exhaustion & Equity Dilution
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PMI | n/a | 1.3x | n/a | 25.0% | -444.3% | -202.1% |
| BEAT | n/a | 0.0x | n/a | 0.0% | 0.0% | -55.5% |
| GIPL | n/a | 121.5x | n/a | 84.0% | -361.7% | -1.2% |
| GTHP | n/a | 31.2x | n/a | 64.0% | -573.1% | -7.4% |
| CTSO | n/a | 0.6x | n/a | 71.6% | -48.9% | -50.0% |
| NMTC | n/a | 1.4x | n/a | 55.7% | -71.5% | -51.1% |
| Peer median | n/a | 1.4x | n/a | 64.0% | -71.5% | -50.0% |
Frequently asked questions about Picard Medical Inc (PMI)
Is PMI stock a good investment?
The cached TradeMates AI model rates Picard Medical Inc as AVOID with an investment score of 18/100. The model views PMI as an extreme-risk microcap micro-float stock with severe cash burn ($15.67M FCF deficit in 2025) and under 6 months of liquidity. The model sees high probability of dilutive financing before Q3 2026, making the equity unsuited for fundamental investors. This is algorithmic model output, not personal investment advice.
Is PMI stock a buy?
The TradeMates model verdict for PMI is AVOID with an investment score of 18/100. Treat this as a model signal to review, not a personal buy recommendation.